Sign In
Buy RMD
$188.63
+2.34 (+1.26%)
At Close: Jun 18, 2026
2 Stocks That Could Grow Your Portfolio Over the Next Decade
09:44am, Tuesday, 15'th Aug 2023
ResMed offers innovative solutions for people suffering from sleep apnea and other chronic diseases. Parker-Hannifin is a leader in motion control technologies and manufactures several related product
Here's Why We Think ResMed Stock Is Undervalued After An 18% Fall In A Month
07:00am, Friday, 11'th Aug 2023
ResMed (NYSE: RMD), a medical equipment company, has seen an 18% fall in a month, underperforming the broader S&P500 index, up 1%.
S&P 500 Gains and Losses Today: Stocks Lose Ground as Hiring Slows
05:55pm, Friday, 04'th Aug 2023
The S&P 500 fell 0.5% on Friday, Aug. 4, 2023, after the Labor Department's latest jobs report showed the pace of hiring slowed.
ResMed's (RMD) Q4 Earnings Miss, Revenues Beat Estimates
01:32pm, Friday, 04'th Aug 2023
ResMed (RMD) records a robust sales performance in fiscal Q4 backed by the ongoing combined availability of cloud-connected AirSense 10 and AirSense 11 sleep devices.
Markets Higher Midday After Upbeat Earnings, July Jobs Report
12:50pm, Friday, 04'th Aug 2023
U.S. equities were higher at midday on Friday, Aug. 4, 2023 on the back of strong earnings reports, while a cooler-than-expected July jobs report raised optimism the Fed could ease back on its campaig
ResMed (RMD) Misses Q4 Earnings Estimates
07:32pm, Thursday, 03'rd Aug 2023
ResMed (RMD) came out with quarterly earnings of $1.60 per share, missing the Zacks Consensus Estimate of $1.67 per share. This compares to earnings of $1.49 per share a year ago.
Why Earnings Season Could Be Great for ResMed (RMD)
10:27am, Wednesday, 02'nd Aug 2023
ResMed (RMD) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
ResMed (RMD) Expands Solutions Portfolio With Somnoware Buyout
10:53am, Friday, 07'th Jul 2023
ResMed (RMD) announces the acquisition of the Somnoware diagnostic management platform.
ResMed to Report Fourth Quarter Fiscal 2023 Earnings on August 3, 2023
04:05pm, Thursday, 06'th Jul 2023
SAN DIEGO, July 06, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2023 on Thursday,
Compound Your Wealth With ResMed
02:57pm, Tuesday, 04'th Jul 2023
ResMed Inc., a leader in digital health and cloud-connected medical devices, is being considered as a potential addition to a healthcare portfolio due to its consistent financial performance and innov
ResMed's (RMD) New Buyout Aids Growth Amid Rising Costs
11:17am, Thursday, 15'th Jun 2023
ResMed's (RMD) respiratory care business witnesses continued customer uptake of bilevel and other non-invasive ventilator solutions worldwide.
Here's Why Investors Should Retain ResMed (RMD) Stock for Now
02:38pm, Thursday, 08'th Jun 2023
Investors continue to be optimistic about ResMed (RMD) backed by the continued demand for digital health solutions.
Medical Equipment Stock to Add to Your Portfolio
02:56pm, Tuesday, 06'th Jun 2023
Medical equipment name ResMed Inc (NYSE:RMD) is looking to snap a four-day win streak, down 0.3% at $221.33 at last glance.
ResMed Announces Participation in the Goldman Sachs 44th Annual Global Healthcare Conference
04:05pm, Monday, 05'th Jun 2023
SAN DIEGO, June 05, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will participate in a fireside chat at the Goldman Sachs 4
ZBH vs. RMD: Which Stock Should Value Investors Buy Now?
12:50pm, Monday, 29'th May 2023
Investors interested in stocks from the Medical - Products sector have probably already heard of Zimmer Biomet (ZBH) and ResMed (RMD). But which of these two stocks offers value investors a better ban
